| Title |
Author |
Type |
Date |
Words |
| Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS). |
|
|
May 20, 2013 |
1432 |
| New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials. |
|
|
May 20, 2013 |
916 |
| Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes. |
|
Financial report |
May 20, 2013 |
625 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1719 |
| Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania. |
|
|
May 20, 2013 |
996 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1786 |
| Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR. |
|
|
May 20, 2013 |
554 |
| CLINICAL TRIALS: SANDRA'S STORY. |
|
|
May 20, 2013 |
359 |
| PATIENTS SIGN UP TO TRIALS. |
|
|
May 20, 2013 |
119 |
| By taking part in trials we cab help everyone; As today marks International Clinical Trials Day, Health Correspondent Julia McWatt looked at the ongoing work in Wales to improve treatments and the issues they face in this process. |
|
|
May 20, 2013 |
971 |
| Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro(TM) to Improve Tacrolimus-Induced Tremors. |
|
Clinical report |
May 20, 2013 |
1039 |
| Local CROs Unite for International Clinical Trials. |
|
|
May 20, 2013 |
603 |
| Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea. |
|
Financial report |
May 20, 2013 |
1238 |
| TRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract Presentations at 2013 ASCO Annual Meeting. |
|
|
May 20, 2013 |
634 |
| Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical Trials With Vortioxetine, An Investigational Compound For Major Depressive Disorder. |
|
|
May 18, 2013 |
1987 |
| Germany : Merck Serono: Detailed Results of Phase III Trial of L-BLP25 in Patients With Non-Small Cell Lung Cancer (START) to be Presented at ASCO. |
|
|
May 17, 2013 |
460 |
| Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy. |
|
|
May 17, 2013 |
576 |
| Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis. |
|
|
May 17, 2013 |
552 |
| Acceliant to Participate in the 4th Annual Clinical Trials Summit in Mumbai. |
|
|
May 16, 2013 |
349 |
| New Clinical Study Finds Masimo rainbow Acoustic Monitoring(TM) Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients. |
|
Clinical report |
May 16, 2013 |
2214 |
| NW Bio Initiates Phase III DCVax-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open. |
|
|
May 16, 2013 |
1240 |
| Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn's Disease. |
|
|
May 15, 2013 |
1480 |
| New Published Clinical Study Shows Masimo PVI Helps Clinicians Assess Fluid Responsiveness in Pediatric Patients. |
|
Clinical report |
May 15, 2013 |
1805 |
| Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device. |
|
|
May 15, 2013 |
699 |
| Trust chosen for pioneering clinical trials. |
|
|
May 15, 2013 |
231 |
| Strategic consulting, design and implementation of an information and awareness campaign for the recruitment of participants in anti-HIV vaccine trials conducted by the Vaccine Research Institute. |
|
|
May 15, 2013 |
101 |
| University Hospitals Case Medical Center Experts to Present Data at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) Addressing Patient and Physician Barriers to Clinical Trials. |
|
Clinical report |
May 15, 2013 |
1020 |
| Bayer Initiates Phase III Trial of Stivarga (regorafenib) Tablets in Patients with Advanced Liver Cancer. |
|
|
May 15, 2013 |
2782 |
| Scientific Design, Development of Polaris's Oncology Distress Management System Published in Contemporary Clinical Trials. |
|
|
May 15, 2013 |
670 |
| Syndax Pharmaceuticals Announces Publication of Clinical Study Demonstrating that Entinostat Targets Resistance Pathways in Breast Cancer. |
|
Clinical report |
May 14, 2013 |
1141 |
| Appointment for the construction of the addenbrookes clinical research centre. |
|
|
May 14, 2013 |
111 |
| AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance. |
|
|
May 14, 2013 |
437 |
| New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb, RRa(TM), and SedLine. |
|
Clinical report |
May 13, 2013 |
1433 |
| Clinical trial to start for new drug to treat muscular dystrophy. |
|
|
May 13, 2013 |
193 |
| Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress. |
|
|
May 13, 2013 |
688 |
| NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part of its Global Health Initiative. |
|
Clinical report |
May 13, 2013 |
797 |
| Dystonia Global Clinical Trials Review, H1, 2013. |
|
|
May 13, 2013 |
2072 |
| Anorexia Nervosa Global Clinical Trials Review, H1, 2013. |
|
|
May 13, 2013 |
2021 |
| Diverticulitis Global Clinical Trials Review, H1, 2013. |
|
|
May 13, 2013 |
1872 |
| Society for Clinical Research Sites (SCRS) Establishes a Strategic Alliance with the Brazilian Society of Investigators. |
|
|
May 13, 2013 |
670 |
| First-in-class Fycompa (perampanel) Pooled Pivotal Phase III Data Published in Epilepsia. |
|
Clinical report |
May 12, 2013 |
2171 |
| Switzerland : Real-world data at ARVO highlight transformational outcomes seen with Lucentis, including lower injection frequency than in original clinical trials. |
|
|
May 9, 2013 |
478 |
| FirstMark's Clinical Study for Predicting Near-Term Myocardial Infarction/Death Published in JACC. |
|
Clinical report |
May 9, 2013 |
600 |
| New Four-Year Data From Boston Scientific Demonstrated WATCHMAN Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The PROTECT AF Trial. |
|
|
May 9, 2013 |
1617 |
| Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma. |
|
|
May 9, 2013 |
1607 |
| IonMed(TM) Announces Successful Completion of the First European Cold Plasma Clinical Study for Closure of Surgical Wounds. |
|
Clinical report |
May 8, 2013 |
742 |
| IonMedTM Announces Successful Completion of the First European Cold Plasma Clinical Study for Closure of Surgical Wounds. |
|
Clinical report |
May 8, 2013 |
747 |
| Neuralstem ALS Trial Investigator And Patient On Sirius XM. |
|
|
May 8, 2013 |
681 |
| Cancer team set to lead clinical trial; Researchers to represent UK in worldwide study. |
|
|
May 8, 2013 |
559 |
| Cholangitis Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
1868 |
| Fatigue Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
2333 |
| Clinical Trial for Newly Diagnosed Glioblastoma Opened in Korea. |
|
|
May 7, 2013 |
561 |
| Piramal Imaging Welcomes Ana M. Catafau, M.D., Ph.D., as VP, Clinical Research and Development, Neurosciences. |
|
|
May 7, 2013 |
914 |
| Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
1498 |
| Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
2522 |
| Diarrhea Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
2354 |
| Dyslexia Global Clinical Trials Review, H1, 2013. |
|
|
May 7, 2013 |
1320 |
| Baxter's Alzheimer's disease drug fails in late-stage trial. |
|
|
May 7, 2013 |
651 |
| Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer. |
|
Clinical report |
May 6, 2013 |
1138 |
| Boston Scientific Completes First-In-Human Clinical Trial of the IntellaTip MiFi(TM) XP Ablation Catheter For Patients With Type 1 Atrial Flutter. |
|
|
May 6, 2013 |
970 |
| Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy. |
|
Conference news |
May 6, 2013 |
937 |
| Anavex invited to file funding application for Phase 2a clinical trial of ANAVEX 2-73. |
|
|
May 6, 2013 |
745 |
| Germany : Bayer Provides Update on Phase II/III Trial of BAY 86-6150. |
|
|
May 4, 2013 |
320 |
| Hep C drug goes after patients' RNA: compound targets genetic material virus uses to replicate. |
Seppa, Nathan |
|
May 4, 2013 |
371 |
| Alzheimer's bane may help in MS: plaque components counter inflammation in mice. |
Seppa, Nathan |
|
May 4, 2013 |
351 |
| Clinical Conductor CTMS and Schulman Associates IRB Join Forces to Simplify Clinical Trial Management. |
|
|
May 3, 2013 |
570 |
| Almirall and Forest Laboratories Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol Combination in COPD. |
|
Report |
May 2, 2013 |
2132 |
| 2013 Update from Families of Spinal Muscular Atrophy on the SMA Drug Pipeline. |
|
|
May 2, 2013 |
633 |
| RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States. |
|
|
May 2, 2013 |
881 |
| RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States. |
|
|
May 2, 2013 |
886 |
| Thousands Of Cats With Kidney Disease Sought For Groundbreaking Clinical Trial. |
|
|
May 2, 2013 |
1035 |
| OncoGenex Announces Plans for the Initiation of the Rainier(TM) Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE plus Gemcitabine in Patients with Metastatic Pancreatic Cancer. |
|
|
May 1, 2013 |
1131 |
| Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease. |
|
|
May 1, 2013 |
824 |
| PER-PATIENT COSTS CLIMB THROUGH CLINICAL TRIAL. |
|
|
May 1, 2013 |
371 |
| ERYTECH PHARMA RECEIVES FDA IND CLEARANCE FOR STUDY. |
|
|
May 1, 2013 |
517 |
| Updated book reflects advances in Infectious Disease Epidemiology. |
Tucker, Charlotte |
|
May 1, 2013 |
504 |
| Lag between trials, publication dates. |
Currie, Donya |
|
May 1, 2013 |
144 |
| Pregnancy outcome in asymptomatic women with abnormal vaginal flora without any treatment and after treatment with vaginal clindamycin and clotrimazole: a randomised controlled trial. |
Gupta, S.; Tripathi, R.; Singh, N.; Bhalla, P.; Ramji, S.; Mala, Y.M. |
Medical condition overview |
May 1, 2013 |
2885 |
| A randomized clinical trial to determine the effect of beta-adrenergic blocking with propranolol on labour. |
Cilliers, J.B.F.; Schoon, M.G.; Bam, R.H.; Niemand, I. |
|
May 1, 2013 |
1578 |
| Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality. |
|
Clinical report |
Apr 30, 2013 |
445 |
| Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401. |
|
Clinical report |
Apr 30, 2013 |
653 |
| Respicardia Receives FDA Approval to Begin the Pivotal Trial of the remede System for the Treatment of Central Sleep Apnea. |
|
|
Apr 30, 2013 |
634 |
| OncoGenex Announces that the Borealis-2(TM) Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment. |
|
|
Apr 30, 2013 |
1113 |
| Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality. |
|
Clinical report |
Apr 30, 2013 |
451 |
| Heart gene therapy trial. |
|
|
Apr 30, 2013 |
124 |
| Pivotal Therapeutics VASCAZEN[R] - REVEAL Trial Top Line Results to be presented at American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2013 Scientific Sessions. |
|
|
Apr 30, 2013 |
730 |
| Lily-Mae set for start of six-month clinical trial. |
|
|
Apr 29, 2013 |
333 |
| Lily-Mae set for start of six-month clinical trial. |
|
|
Apr 29, 2013 |
333 |
| CVRx Launches HOPE4HF(TM) Clinical Trial Evaluating Barostim neo(TM) in Heart Failure Patients. |
|
Clinical report |
Apr 29, 2013 |
1285 |
| Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013. |
|
Clinical report |
Apr 29, 2013 |
1104 |
| Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting. |
|
|
Apr 29, 2013 |
929 |
| Monoclonal Antibody with Xencor's High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia. |
|
|
Apr 26, 2013 |
629 |
| The Week In Science: Baby Turtle Robots, HIV Vaccine Trial Stopped, Gray Wolves Might Lose Protections. |
|
|
Apr 26, 2013 |
645 |
| Profound Medical Announces Initiation of TULSA Clinical Trial for Treatment of Localized Prostate Cancer. |
|
|
Apr 25, 2013 |
601 |
| Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement to Evaluate the Efficacy and Safety of PER977 to Reverse the Anticoagulant Activity of the Investigational, Oral, Once-Daily Factor Xa Inhibitor Edoxaban. |
|
|
Apr 25, 2013 |
1491 |
| Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement to Evaluate the Efficacy and Safety of PER977 to Reverse the Anticoagulant Activity of the Investigational, Oral, Once-Daily Factor Xa Inhibitor Edoxaban. |
|
|
Apr 25, 2013 |
1632 |
| Cellular Biomedicine Group Provides Update and 2013 Milestones. |
|
|
Apr 25, 2013 |
1158 |
| Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee. |
|
|
Apr 25, 2013 |
882 |
| Lixte Biotechnology Announces Initiation Of A Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100. |
|
|
Apr 25, 2013 |
603 |
| Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial. |
|
Clinical report |
Apr 24, 2013 |
1501 |
| Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimer's Disease Patients. |
|
|
Apr 24, 2013 |
866 |
| XBiotech Enrolls First Patient in Phase III Pivotal Trial of Xilonix(TM). |
|
|
Apr 24, 2013 |
644 |
| New Data from AbbVie's Phase IIb Aviator Trial Demonstrate High Sustained Viral Response Rates Across Multiple Patient Types with HCV Genotype 1. |
|
|
Apr 23, 2013 |
3127 |
| New Data from AbbVie's Phase IIb Aviator Trial Demonstrate High Sustained Viral Response Rates Across Multiple Patient Types with HCV Genotype 1. |
|
|
Apr 23, 2013 |
2833 |
| ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy. |
|
|
Apr 23, 2013 |
1602 |
| Halozyme Initiates Randomized Phase 2 Trial of PEGPH20 in Pancreatic Cancer. |
|
|
Apr 23, 2013 |
908 |
| Celsion Corporation Provides Business Update. |
|
|
Apr 23, 2013 |
1099 |
| Patient-Centered Outcomes Research Institute to Invest Up to $68 Million to Develop a National Patient-Centered Clinical Research Network. |
|
|
Apr 23, 2013 |
712 |
| Alliance for Clinical Research Excellence and Safety (ACRES) announces new Board of Directors and Global Advisory Board. |
|
|
Apr 22, 2013 |
894 |
| FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder. |
|
|
Apr 22, 2013 |
1109 |
| BAROnova Announces the Results of ENDObesity I Clinical Trial. |
|
|
Apr 22, 2013 |
586 |
| Raising Awareness About Cancer Clinical Trials In Multicultural Communities. |
|
|
Apr 22, 2013 |
720 |
| Presage Biosciences Announces First Patient in Clinical Trial of CIVO(TM) Precision Oncology. |
|
|
Apr 19, 2013 |
884 |
| Ceregene Reports Data From Parkinson's Disease Phase 2b Study. |
|
Clinical report |
Apr 19, 2013 |
1444 |
| Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.). |
|
|
Apr 19, 2013 |
455 |
| Phase I clinical trial for H5N1 vaccine yields positive results. |
|
|
Apr 18, 2013 |
388 |
| Resverlogix Completes Dosing In ASSURE Clinical Trial. |
|
|
Apr 18, 2013 |
1149 |
| Resverlogix Completes Dosing in ASSURE Clinical Trial. |
|
|
Apr 18, 2013 |
982 |
| Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHD. |
|
|
Apr 18, 2013 |
1137 |
| ChromaDex Initiates First Human Clinical Study for Its New Caffeine Ingredient Technology, PURENERGY(TM). |
|
|
Apr 18, 2013 |
981 |
| Resverlogix Completes Dosing In ASSURE Clinical Trial. |
|
|
Apr 18, 2013 |
1225 |
| Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo. |
|
|
Apr 18, 2013 |
762 |
| Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients. |
|
|
Apr 18, 2013 |
985 |
| Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug. |
|
|
Apr 18, 2013 |
857 |
| ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes. |
|
|
Apr 18, 2013 |
823 |
| Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx, an Abuse-Deterrent, Extended-Release Opioid Product. |
|
Clinical report |
Apr 17, 2013 |
779 |
| Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721. |
|
|
Apr 17, 2013 |
1156 |
| Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis. |
|
|
Apr 17, 2013 |
1133 |
| FDA approves Phase II of stem cell trial for ALS led by U-M's Dr. Eva Feldman. |
|
|
Apr 17, 2013 |
638 |
| JHP Pharmaceuticals to Produce Supplies of Biologic Drug Product for Late-Phase Clinical Trials. |
|
|
Apr 17, 2013 |
476 |
| Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk. |
|
Clinical report |
Apr 17, 2013 |
655 |
| IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine. |
|
|
Apr 17, 2013 |
1795 |
| Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine. |
|
|
Apr 17, 2013 |
1770 |
| Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia. |
|
|
Apr 16, 2013 |
634 |
| Rhythm Initiates Phase 2 Clinical Trial of Ghrelin Prokinetic RM-131 for Lower GI Functional Disorders. |
|
|
Apr 16, 2013 |
765 |
| Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes. |
|
|
Apr 16, 2013 |
1323 |
| Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding. |
|
|
Apr 16, 2013 |
570 |
| NW Bio's Phase III Trial With DCVax-L For Brain Cancer "Adopted" As A National Priority Trial In UK. |
|
|
Apr 16, 2013 |
819 |
| Novel Cancer Immunotherapy set to enter Clinical Trials. |
|
|
Apr 16, 2013 |
457 |
| HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC). |
|
|
Apr 16, 2013 |
595 |
| Novel Cancer Immunotherapy set to enter Clinical Trials. |
|
|
Apr 16, 2013 |
467 |
| Boston Scientific Begins Clinical Trial To Evaluate New Pacing System in MRI Environment. |
|
|
Apr 15, 2013 |
1211 |
| UC San Diego Again Offers Workshop on Clinical Trials Administration in Latin America. |
|
|
Apr 15, 2013 |
533 |
| NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease. |
|
|
Apr 15, 2013 |
629 |
| BHR Pharma Announces 1,000th Enrolled Patient in SyNAPSe Trial. |
|
|
Apr 15, 2013 |
660 |
| Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections. |
|
|
Apr 15, 2013 |
1043 |
| Biopharmaceutical Companies Transform Clinical Trial Strategies for Success in Global Marketplace. |
|
|
Apr 13, 2013 |
557 |
| Clinical trial investigates improving memory. |
|
|
Apr 11, 2013 |
309 |
| Results from Cardio3BioSciences C-CURE Trial Published in the Journal of the American College of Cardiology. |
|
|
Apr 11, 2013 |
1258 |
| Results from Cardio3BioSciences C-CURE Trial Published in the Journal of the American College of Cardiology. |
|
|
Apr 11, 2013 |
1263 |
| Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study. |
|
|
Apr 11, 2013 |
1276 |
| OncoGenex Announces Plans for the Initiation of the Spruce(TM) Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer. |
|
Clinical report |
Apr 11, 2013 |
1012 |
| Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure. |
|
Clinical report |
Apr 11, 2013 |
719 |
| Sixteen International Parkinson's Disease Organizations Join Forces to Raise Global Awareness for Clinical Trial Participation. |
|
|
Apr 11, 2013 |
1017 |
| inVentiv Health Forms Strategic Alliance With Bell Medical Solutions, One Of Japan's Top Clinical Research Organizations. |
|
|
Apr 11, 2013 |
1201 |
| Sixteen International Parkinson's Disease Organizations Join Forces to Raise Global Awareness for Clinical Trial Participation. |
|
|
Apr 11, 2013 |
1033 |
| NIH trial shows promising results in treating a lymphoma in young people. |
|
|
Apr 11, 2013 |
138 |
| Lipid Therapeutics Successfully Files a US IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis. |
|
|
Apr 10, 2013 |
693 |
| Lipid Therapeutics Successfully Files a US IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis. |
|
|
Apr 10, 2013 |
698 |
| DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083. |
|
|
Apr 10, 2013 |
1954 |
| Regentis Biomaterials Expands Clinical Study of GelrinC for Cartilage Repair. |
|
Clinical report |
Apr 10, 2013 |
671 |
| Partnerships In Clinical Trials Nominates Christine Pierre for Clinical Trial Business Woman of the Year. |
|
|
Apr 10, 2013 |
501 |
| Clinical Trial Sites for First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis Announced by Galectin Therapeutics. |
|
|
Apr 9, 2013 |
1174 |
| Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial. |
|
|
Apr 8, 2013 |
600 |
| Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting. |
|
Report |
Apr 8, 2013 |
610 |
| Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor. |
|
Report |
Apr 8, 2013 |
1521 |
| Novum to Open State-of-the-Art Clinical Research Facility in Houston, TX. |
|
|
Apr 5, 2013 |
373 |
| Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases. |
|
|
Apr 5, 2013 |
1238 |
| Industry group supports uniform approach to transparency of clinical trial data. |
|
|
Apr 5, 2013 |
501 |
| Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA. |
|
|
Apr 5, 2013 |
454 |
| PharmaSeek Implements Allegro CTMS for Clinical Research Site Management. |
|
|
Apr 4, 2013 |
814 |
| VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial. |
|
Clinical report |
Apr 4, 2013 |
788 |
| Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop. |
|
|
Apr 4, 2013 |
1449 |
| Perceptive Informatics Improves Clinical Trial Management With New Release Of IMPACT CTMS Solution. |
|
|
Apr 3, 2013 |
1434 |
| Applied Clinical Trials Magazine Advises Clinical Trials to Put Patients First in New Peer-Reviewed Article. |
|
|
Apr 3, 2013 |
477 |
| Cellular Biomedicine Group Marks the Launch of Clinical Trial for Knee Osteoarthritis (KOA). |
|
|
Apr 3, 2013 |
677 |
| Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion(TM) for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun. |
|
|
Apr 2, 2013 |
967 |
| NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer. |
|
|
Apr 2, 2013 |
1315 |
| Children's Hospital of Wisconsin and Medical College of Wisconsin launch clinical trial for treatment of childhood brain tumors. |
|
|
Apr 2, 2013 |
1127 |
| Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden. |
|
|
Apr 1, 2013 |
1120 |
| Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent. |
|
Company overview |
Apr 1, 2013 |
517 |
| Dengue vaccine trial shows promise. |
Currie, Donya |
|
Apr 1, 2013 |
171 |
| Uncaria tomentosa-adjuvant treatment for breast cancer: clinical trial. |
|
|
Apr 1, 2013 |
154 |
| Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system? |
Jones, Britney; Syme, Rachel; Eliasziw, Misha; Eigl, Bernhard J. |
|
Apr 1, 2013 |
3385 |
| Clinical studies on infant nutrition. |
|
Clinical report |
Apr 1, 2013 |
129 |
| Smallpox Vaccine Clinical Study Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting Healthy M/F Age 18-40. |
|
Clinical report |
Mar 29, 2013 |
534 |
| Anaeropharma Science Initiates First-in-Human Trial of Novel Recombinant Bifidobacterial Anti-cancer Agent APS001F for Advanced Solid Tumors. |
|
|
Mar 28, 2013 |
448 |
| Promising Results in Trials With Non-chemotherapy Treatments for Leukemias to be Presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013. |
|
|
Mar 28, 2013 |
399 |
| Oncolytics Biotech[R] Inc. Meets Primary Overall Statistical Endpoint in U.S. Phase 2 Study of REOLYSIN[R] in Squamous Cell Lung Cancer. |
|
|
Mar 28, 2013 |
908 |
| Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials. |
|
|
Mar 28, 2013 |
1103 |
| Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids. |
|
|
Mar 27, 2013 |
803 |
| Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis. |
|
Clinical report |
Mar 27, 2013 |
1286 |
| CureVac Initiates Phase 2b Clinical Trial of its mRNA-Based Cancer Vaccine in Patients with Castration-Resistant Prostate Cancer. |
|
|
Mar 27, 2013 |
700 |
| CureVac Initiates Phase 2b Clinical Trial of its mRNA-Based Cancer Vaccine in Patients with Castration-Resistant Prostate Cancer. |
|
|
Mar 27, 2013 |
726 |
| Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S' Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials. |
|
|
Mar 27, 2013 |
1668 |
| Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S' Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials. |
|
|
Mar 27, 2013 |
1675 |
| Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial. |
|
|
Mar 26, 2013 |
1032 |
| Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia. |
|
|
Mar 26, 2013 |
951 |
| MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013. |
|
Conference news |
Mar 26, 2013 |
754 |
| OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients. |
|
|
Mar 25, 2013 |
1041 |
| Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data from XIAFLEX (CCH) Frozen Shoulder Syndrome Phase IIa Study. |
|
|
Mar 25, 2013 |
2568 |
| Adverse Effects in AIM-HIGH trial of Niaspan are Consistent With the Results Reported From HPS2-THRIVE Trial of ER Niacin Plus Laropiprant. |
|
|
Mar 25, 2013 |
711 |
| Adverse Effects in AIM-HIGH trial of Niaspan are Consistent With the Results Reported From HPS2-THRIVE Trial of ER Niacin Plus Laropiprant. |
|
|
Mar 25, 2013 |
717 |
| Research facility to undertake land based tank trials for treatments of AGD on salmon. |
|
|
Mar 23, 2013 |
125 |
| 600th Heart Attack Patient Recruited into Phase III CicloMulsion CIRCUS Trial. |
|
|
Mar 22, 2013 |
1256 |
| Cerulean Announces Results from Phase 2b Lung Cancer Trial. |
|
Clinical report |
Mar 22, 2013 |
668 |
| Affinium Pharmaceuticals Announces Positive Efficacy, Safety, and Tolerability Results from Phase 2a Clinical Trial of Oral AFN-1252 in Acute Bacterial Skin & Skin Structure Infections. |
|
|
Mar 21, 2013 |
950 |
| Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia. |
|
|
Mar 21, 2013 |
1296 |
| Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma. |
|
|
Mar 21, 2013 |
856 |
| Testicular Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Mar 21, 2013 |
1958 |
| Oral Cancer Global Clinical Trials Review, H2, 2012. |
|
|
Mar 21, 2013 |
2052 |
| Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes. |
|
|
Mar 21, 2013 |
1580 |
| ePharmaSolutions and CenterWatch Partner to Improve Patient Eligibility and Access to Clinical Trials. |
|
|
Mar 21, 2013 |
655 |
| Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial. |
|
|
Mar 21, 2013 |
1024 |
| Affinium Pharmaceuticals Announces Positive Efficacy, Safety, and Tolerability Results from Phase 2a Clinical Trial of Oral AFN-1252 in Acute Bacterial Skin & Skin Structure Infections. |
|
Clinical report |
Mar 20, 2013 |
985 |
| First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals' Lead Therapeutic Candidate for Treatment of Migraine, ALD403. |
|
Clinical report |
Mar 20, 2013 |
719 |
| NextDocs and Microsoft Mobilize Clinical Trials with Trial Exchange and Windows 8. |
|
|
Mar 20, 2013 |
629 |
| Clinical Trials and Medical Research in Texas Create Jobs and Save Lives. |
|
|
Mar 20, 2013 |
445 |
| Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine. |
|
|
Mar 19, 2013 |
553 |
| Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta (linagliptin) tablets in patients with type 2 diabetes and albuminuria. |
|
|
Mar 19, 2013 |
2019 |
| EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer. |
|
|
Mar 19, 2013 |
754 |
| Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma. |
|
Financial report |
Mar 19, 2013 |
1692 |
| Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013. |
|
|
Mar 19, 2013 |
2652 |
| MacroCure Chosen to Present Results of Multi-Center Trial of CureXCell at Upcoming Global Diabetic Foot Conference, (DFCon) in Hollywood California USA. |
|
Conference news |
Mar 18, 2013 |
528 |
| Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis. |
|
|
Mar 18, 2013 |
892 |
| Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update. |
|
|
Mar 18, 2013 |
4032 |
| Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis. |
|
|
Mar 18, 2013 |
902 |
| Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology. |
|
Report |
Mar 18, 2013 |
1129 |
| Anavex comments on FDA plan to expedite approval of new Alzheimer's drugs. |
|
|
Mar 18, 2013 |
820 |
| ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital. |
|
|
Mar 18, 2013 |
389 |
| TheraVida Presents Positive Phase 2 Data for Tolenix(TM) (THVD-201) in Patients with Overactive Bladder at the 28th Annual Congress of the European Urological Association. |
|
|
Mar 18, 2013 |
922 |
| BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report. |
|
|
Mar 18, 2013 |
2203 |
| Drugs still being approved without clinical trials. |
|
|
Mar 17, 2013 |
370 |
| Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update. |
|
|
Mar 15, 2013 |
5686 |
| OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study. |
|
Clinical report |
Mar 15, 2013 |
458 |
| Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease. |
|
|
Mar 14, 2013 |
1147 |
| The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology's CYT003 for the Treatment of Allergic Asthma. |
|
Clinical report |
Mar 13, 2013 |
975 |
| N30 Pharmaceuticals Announces First Patient Treated in Clinical Trial of N6022 in Cystic Fibrosis. |
|
Clinical report |
Mar 13, 2013 |
836 |
| Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial. |
|
Clinical report |
Mar 13, 2013 |
746 |
| Sosei Announces Initiation of Phase III Study for SO-1105 for the Treatment of Oropharyngeal Candidiasis. |
|
|
Mar 12, 2013 |
527 |
| Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat. |
|
|
Mar 12, 2013 |
710 |
| Cohera Medical, Inc. Receives Approval To Begin Human Clinical Trials Of Sylys(TM) Surgical Sealant In Europe. |
|
|
Mar 12, 2013 |
515 |
| Ampio Receives FDA Acceptance of its Patient Outcome for Premature Ejaculation (POPE) Questionnaire, Paving the Way for its US Pivotal Trial on Zertane(TM). |
|
|
Mar 11, 2013 |
1092 |
| Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available. |
|
|
Mar 9, 2013 |
805 |
| Cardiac Dimensions Completes Patient Enrollment in TITAN II Clinical Trial. |
|
|
Mar 8, 2013 |
795 |
| Clinical Trial Results for Dune Medical Devices' MarginProbe System Presented at 66th Annual SSO Cancer Symposium. |
|
|
Mar 7, 2013 |
917 |
| Boston Scientific Updates PREVAIL Late Breaking Clinical Trials Presentation. |
|
|
Mar 6, 2013 |
1157 |
| Oncolytics Biotech[R] Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN[R] in Non-Small Cell Lung Cancer. |
|
|
Mar 5, 2013 |
794 |
| First Patient Treated in U.S. No-Drain Clinical Study of Cohera Medical's TissuGlu Surgical Adhesive. |
|
Clinical report |
Mar 5, 2013 |
744 |
| DCVax-Direct Phase I/II Trial For All Inoperable Solid Tumors Is Expected To Produce Ongoing Results In 2013. |
|
|
Mar 5, 2013 |
1086 |
| Senesco Technologies Provides Corporate Update. |
|
|
Mar 5, 2013 |
2169 |
| PSI Announces Collaboration With Synta Pharmaceuticals for the GALAXY-2 Phase III Non-Small Cell Lung Cancer Trial. |
|
|
Mar 5, 2013 |
305 |
| Denmark : EU GRANT for placental malaria vaccine trial. |
|
|
Mar 5, 2013 |
368 |
| Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis. |
|
|
Mar 5, 2013 |
916 |
| Agility Clinical Partners with PSR Orphan Drug Experts. |
|
|
Mar 5, 2013 |
726 |
| Reanalysis of Clinical Trial Data Confirms LipiGesic M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms. |
|
|
Mar 5, 2013 |
736 |
| ePharmaSolutions Launches Self-Configurable Clinical Trial Portal and eTMF for Contract Research Organizations. |
|
|
Mar 5, 2013 |
600 |
| ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals. |
|
|
Mar 4, 2013 |
352 |
| Clinical trial: study aims to measure efficacy of high-tech patient simulators. |
Bradley, Paul |
|
Mar 4, 2013 |
1303 |
| DBV Technologies reports Full Year 2012 financial results and provides R&D update. |
|
Financial report |
Mar 4, 2013 |
2182 |
| PsiOxus Therapeutics Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102. |
|
|
Mar 4, 2013 |
742 |
| NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson's Disease. |
|
|
Mar 4, 2013 |
659 |
| Shape Pharmaceuticals Provides Update on SHP-141 Topical HDAC Inhibitor Clinical Development for Cutaneous T Cell Lymphoma. |
|
|
Mar 4, 2013 |
690 |
| VOICE Trial Results Underscore Need to Accelerate Development of Additional HIV Prevention Options for Women. |
|
|
Mar 4, 2013 |
1218 |
| OPKO Health Completes Acquisition of Two Phase 3 Products. |
|
|
Mar 4, 2013 |
1052 |
| Tenaxis Medical, Inc. Receives FDA Approval for its ArterX Surgical Sealant. |
|
|
Mar 4, 2013 |
540 |
| Cliantha Research Partners with Acceliant for Its Clinical Trials. |
|
|
Mar 1, 2013 |
485 |
| Synteract and Harrison Clinical Research Close Deal to Form Multinational CRO. |
|
|
Mar 1, 2013 |
971 |
| Synteract and Harrison Clinical Research Close Deal to Form Multinational CRO. |
|
|
Mar 1, 2013 |
975 |
| Vitamin D-mentia: randomized clinical trials should be the next step. |
|
|
Mar 1, 2013 |
201 |
| L-carnitine treatment for congestive heart failure--experimental and clinical study. |
|
Clinical report |
Mar 1, 2013 |
260 |
| Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. |
|
|
Mar 1, 2013 |
183 |
| Clinical trials get technical. |
Mayberry, Jonnatha |
|
Mar 1, 2013 |
1091 |
| Executive Roundtable on Adaptive Design Trials Identifies Key Factors That Dramatically Increase Development Efficiency and Productivity. |
|
Discussion |
Feb 28, 2013 |
729 |
| Clinical Trial Results of the Artificial Pancreas Project, Designed to Provide a Real Solution for Patients with Diabetes, Published Today in the new Issue of the Journal New England Journal of Medicine. |
|
Clinical report |
Feb 28, 2013 |
915 |
| Neovasc's COSIRA clinical trial protocol selected for publication in peer-reviewed journal. |
|
|
Feb 28, 2013 |
1130 |
| Clinical Trial Results of the Artificial Pancreas Project, Designed to Provide a Real Solution for Patients with Diabetes, Published Today in the new Issue of the Journal New England Journal of Medicine. |
|
Clinical report |
Feb 28, 2013 |
926 |
| Heart Test Labs Clinical Trial Within the Canadian Healthcare System. |
|
|
Feb 28, 2013 |
479 |
| Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer's disease via beta amyloid signature in the eyes. |
|
|
Feb 28, 2013 |
849 |
| EnVivo Pharmaceuticals Announces Initiation of Phase 3 Clinical Trial Program of EVP-6124 in Schizophrenia. |
|
Clinical report |
Feb 28, 2013 |
1105 |
| CytRx Reaches Patient Enrollment Target in Global Phase 2b Clinical Trial with Tamibarotene as First-Line Treatment for Non-Small-Cell Lung Cancer. |
|
|
Feb 28, 2013 |
1020 |
| Spain : Zeltia announces that subsidiary Sylentis has commenced Phase II clinical trials with its compound SYL1001 for treating eye discomfort associated with dry eye syndrome. |
|
|
Feb 28, 2013 |
152 |
| BioElectronics Expands Clinical Research. |
|
Clinical report |
Feb 28, 2013 |
513 |
| CSL Behring Receives FDA Approval to Expand the Indication for Corifact. |
|
|
Feb 28, 2013 |
914 |
| Invaron Pharmaceuticals and the Center for Assisted Reproduction (CARE) Initiate Investigator Led Phase III Clinical Study on INVOcell(TM). |
|
|
Feb 28, 2013 |
523 |
| Cliantha Research Partners with Acceliant for its Clinical Trials. |
|
|
Feb 27, 2013 |
754 |
| Ampio Pharmaceuticals Initiates Clinical Trial of Optina(TM) in Diabetic Macular Edema (DME): First Patient Dosed. |
|
|
Feb 27, 2013 |
1382 |
| Theorem Clinical Research Releases Booklets to Provide ICH GCP Guidance For In Vitro and Investigational Product Trials. |
|
|
Feb 27, 2013 |
520 |
| Inviragen Advances DENVax into Second Stage of Ongoing Phase 2 Clinical Study. |
|
Clinical report |
Feb 27, 2013 |
800 |
| Rasheda Ali on National and Local News: BrainStorm's ALS Clinical Trial Results Exceeded Expectations. |
|
|
Feb 27, 2013 |
600 |
| Acurian, the Patient Enrollment and Retention Specialist, Achieves 15-Year Milestone. |
|
|
Feb 27, 2013 |
376 |
| AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data. |
|
|
Feb 27, 2013 |
732 |
| Cardica Updates Enrollment Progress In European Clinical Trial. |
|
|
Feb 27, 2013 |
579 |
| Expanding Orthopedics Announces the Launch of an Additional Clinical Study in Germany to Evaluate its XPED Expanding Pedicle Screw System. |
|
Clinical report |
Feb 26, 2013 |
570 |
| AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation. |
|
Financial report |
Feb 26, 2013 |
934 |
| Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation. |
|
|
Feb 26, 2013 |
1075 |
| Quantity and Quality of Sites is Crucial to Phase 1 Clinical Trials. |
|
|
Feb 26, 2013 |
430 |
| Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on Oxford Gene Technology's Patented Functional Protein Array. |
|
|
Feb 25, 2013 |
490 |
| EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma. |
|
Company overview |
Feb 25, 2013 |
1506 |
| Okairos Initiates Phase I Clinical Trial Evaluating Vaccine against RSV Infections. |
|
|
Feb 25, 2013 |
602 |
